Loading…
Zhengye Biotechnology Holding Limited is projected to decline to $0.8177 by 2027, a 0% move from its current price of $0.82. ZYBT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.7862 | $0.8197 | $0.8545 | -0.04% |
| Jul 13 | $0.7724 | $0.8193 | $0.869 | -0.08% |
| Jul 14 | $0.7619 | $0.819 | $0.8803 | -0.13% |
| Jul 15 | $0.7532 | $0.8186 | $0.8898 | -0.17% |
| Jul 16 | $0.7455 | $0.8183 | $0.8982 | -0.21% |
| Jul 17 | $0.7386 | $0.8179 | $0.9058 | -0.25% |
| Jul 18 | $0.7322 | $0.8176 | $0.9129 | -0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7322 | $0.8176 | $0.9129 | -0.29% |
| Week 2 | $0.6975 | $0.8152 | $0.9527 | -0.59% |
| Week 3 | $0.6715 | $0.8128 | $0.9838 | -0.88% |
| Week 4 | $0.6501 | $0.8104 | $1.01 | -1.17% |
| Week 5 | $0.6315 | $0.8081 | $1.03 | -1.46% |
| Week 6 | $0.615 | $0.8057 | $1.06 | -1.75% |
| Week 7 | $0.6001 | $0.8033 | $1.08 | -2.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zhengye Biotechnology Holding Limited is a healthcare company focused on veterinary vaccines for livestock in the People's Republic of China. It engages in the research, development, manufacture, and sale of vaccines for swine, cattle, goats, sheep, poultry, and dogs, including monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine.
The company also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs, and exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China.
Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Zhengye Biotechnology Holding Limited (ZYBT) currently trades at $0.7678 per share, with a market capitalization of $36.39M and a market rank of 4710.
The near-term price outlook shows a mix of neutral and upside potential in the forecast. For 2026 the min is $0.646, the avg is $0.7678, the max is $0.9799, with ROI of 0 and sentiment NEUTRAL.
Technically, the stock shows bearish sentiment with RSI14 of 50. The SMA50 is $0.8489 and the SMA200 is $1.53. A support level is at $0.646 and a resistance level at $0.90. The 30-day price range spans from $0.5712 to $1.03, and annualized volatility is 90%.
A major floor 36.4% below — a decisive break under it would weaken the trend.
The nearest floor, 21.2% below — buyers have tended to step in here.
The nearest ceiling, 9.8% above — a clean break opens room to run.
A major ceiling 46.3% above — clearing it would confirm fresh momentum.
Key ZYBT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZYBT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7574 | Buy | $0.7574 | Buy |
| MA 10 | $0.7192 | Buy | $0.7463 | Buy |
| MA 20 | $0.7563 | Buy | $0.7614 | Buy |
| MA 50 | $0.8409 | Sell | $0.8243 | Sell |
| MA 100 | $0.8659 | Sell | $1.05 | Sell |
| MA 200 | $1.41 | Sell | $1.87 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.46 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 32.66 | Neutral |
| Williams %R (14) | -1.47 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -0.26 | Sell |
| Bollinger %B (20,2) | 0.60 | Neutral |
| Stochastic %K (14) | 98.53 | Sell |
| TRIX (15) | -0.71 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 68.35 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 0.80 | Buy |
| ADX (14) | 15.07 | Neutral |
| ATR (14) | 0.03 | Info |
The near-term technical picture shows bearish sentiment.
RSI14 is 50, with the 50-day simple moving average at $0.8489 and the 200-day simple moving average at $1.53.
Key levels to watch are support at $0.646 and resistance at $0.90, with the 30-day range extending from $0.5712 to $1.03.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.646 | $0.82 | $1.05 | 0% | Neutral | |
| $0.6192 | $0.8177 | $1.16 | 0% | Neutral | |
| $0.5802 | $0.8016 | $1.20 | -2% | Neutral | |
| $0.5844 | $0.8387 | $1.30 | +2% | Neutral | |
| $0.7093 | $1.05 | $1.69 | +28% | Bullish | |
| $0.8826 | $1.35 | $2.24 | +65% | Bullish | |
| $0.8449 | $1.33 | $2.27 | +63% | Bullish | |
| $0.7982 | $1.30 | $2.26 | +58% | Bullish | |
| $0.8334 | $1.39 | $2.47 | +70% | Bullish | |
| $0.7601 | $1.30 | $2.36 | +59% | Bullish | |
| $1.10 | $2.14 | $4.21 | +161% | Bullish | |
| $1.92 | $4.27 | $9.44 | +421% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.646 | $0.82 | $0.9872 | +0.00% |
| August 2026 | $0.652 | $0.7808 | $0.9681 | -4.78% |
| September 2026 | $0.6519 | $0.7892 | $0.9948 | +1.08% |
| October 2026 | $0.6734 | $0.8228 | $1.05 | +4.25% |
| November 2026 | $0.6591 | $0.8118 | $1.05 | -1.34% |
| December 2026 | $0.6452 | $0.8006 | $1.05 | -1.38% |
Click any year to see its month-by-month ZYBT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ZYBT is projected to trade between $0.646 and $1.05, averaging $0.82 — a potential gain of 0% from today's $0.82. Price action looks broadly range-bound.
Zhengye Biotechnology Holding Limited's 2027 outlook centres on $0.8177, within a $0.6192 to $1.16 range. That is 0% versus the projected 2026 average. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, ZYBT could reach as high as $1.20, with a base case around $0.8016 and support toward $0.5802 — roughly -2% from $0.82. Price action looks broadly range-bound.
Expect ZYBT to range from $0.5844 to $1.30 through 2029. The $0.8387 average target implies a +2% move from current prices. That is up +5% on the projected 2028 average. A consolidation phase looks the most probable path here.
The ZYBT price prediction for 2030 points to an average of $1.05 (low $0.7093, high $1.69) — a potential gain of +28% on today's $0.82. Momentum favours further upside here.
In 2031, ZYBT is projected to trade between $0.8826 and $2.24, averaging $1.35 — a potential gain of +65% from today's $0.82. That is up +28% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Zhengye Biotechnology Holding Limited's 2032 outlook centres on $1.33, within a $0.8449 to $2.27 range. That is -1% versus the projected 2031 average. That marks a +63% change versus current levels. Momentum favours further upside here.
By 2033, ZYBT could reach as high as $2.26, with a base case around $1.30 and support toward $0.7982 — roughly +58% from $0.82. Buyers look set to stay in control over this stretch.
Expect ZYBT to range from $0.8334 to $2.47 through 2034. The $1.39 average target implies a +70% move from current prices. That is up +7% on the projected 2033 average. Momentum favours further upside here.
The ZYBT price prediction for 2035 points to an average of $1.30 (low $0.7601, high $2.36) — a potential gain of +59% on today's $0.82. Buyers look set to stay in control over this stretch.
In 2040, ZYBT is projected to trade between $1.10 and $4.21, averaging $2.14 — a potential gain of +161% from today's $0.82. That is up +64% on the projected 2035 average. Momentum favours further upside here.
Zhengye Biotechnology Holding Limited's 2050 outlook centres on $4.27, within a $1.92 to $9.44 range. That is up +100% on the projected 2040 average. That marks a +421% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ZYBT today (≈ 1,219.512195 ZYBT) could be worth
$5,206.65
+$4,206.65 (+421%) by 2050 · US Dollar
Based on the average projected ZYBT price of $4.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZYBTwould be worth at today's price.
$1,000 invested in ZYBT on Jul 10, 2025 (≈ 149.253736 ZYBT) would be worth
$122.39
-$877.61 (-87.8%) today · 0.12× · US Dollar
Based on a ZYBT entry price of $6.7 vs. today's $0.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.646 | $1,269.35 | +26.9% |
| 1 month ago | $0.9 | $911.11 | -8.9% |
| 3 months ago | $1.06 | $773.58 | -22.6% |
| 6 months ago | $1.17 | $699.66 | -30.0% |
| 1 year ago | $6.7 | $122.39 | -87.8% |
| All time (1.5y) ago | $4.86 | $168.72 | -83.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZYBT forecast.
Our base-case forecast reaches $1.60 around 2040.
Implied market cap at $1.60: $75.83M
The multi-year forecast depicts a shift from neutral to bullish sentiment after the initial years, with notable gains projected into the 2030s and beyond.
For 2030, the average price is $0.893 with ROI 16.3% (sentiment NEUTRAL). By 2031-2035, the outlook turns bullish, with 2031 average $1.16 and ROI 50.6%, 2032 average $1.14 and ROI 48.7%, 2033 average $1.10 and ROI 42.8%, 2034 average $1.16 and ROI 50.9%, and 2035 average $1.07 and ROI 38.9%.
Longer-range milestones include 2040 with average $1.72 and ROI 124.7%, and 2050 with average $3.32 and ROI 331.9%. These figures illustrate a potential growth path, but they are estimates, not guarantees, and depend on future market dynamics.
Tap a question to reveal the answer.
2030 expected average price is $0.893 with ROI 16.3% (sentiment NEUTRAL); the forecast min is $0.5877 and max is $1.47.
Forecasts show neutral sentiment in 2026 and bullish sentiment from 2031 onward, with ROIs ranging from 50.6% in 2031 to 331.9% in 2050. These are estimates and not guarantees.
Yes, the 2031 forecast shows an average price of $1.16, which is above $1, with ROI 50.6%.
Bearish sentiment with RSI 50; SMA50 is $0.8489 and SMA200 is $1.53. Support is at $0.646 and resistance at $0.90. The 30-day range is $0.5712–$1.03, and annualized volatility is 90%.
Current price is $0.7678, market cap is $36.39M, and rank is 4710.
Zhengye Biotechnology Holding Limited Community Discussion
0Share your Zhengye Biotechnology Holding Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.